DOI QR코드

DOI QR Code

Poloxamer 407 Hydrogels for Intravesical Instillation to Mouse Bladder: Gel-Forming Capacity and Retention Performance

  • Kim, Sang Hyun (Drug Delivery Research Lab, College of Pharmacy, Chung-Ang University) ;
  • Kim, Sung Rae (Drug Delivery Research Lab, College of Pharmacy, Chung-Ang University) ;
  • Yoon, Ho Yub (Drug Delivery Research Lab, College of Pharmacy, Chung-Ang University) ;
  • Chang, In Ho (Department of Urology, College of Medicine, Chung-Ang University) ;
  • Whang, Young Mi (Department of Urology, College of Medicine, Chung-Ang University) ;
  • Cho, Min Ji (Department of Urology, College of Medicine, Chung-Ang University) ;
  • Kim, Myeong Joo (Department of Urology, College of Medicine, Chung-Ang University) ;
  • Kim, Soo Yeon (Immunotherapeutics Branch, Research Institute, National Cancer Center) ;
  • Lee, Sang Jin (Immunotherapeutics Branch, Research Institute, National Cancer Center) ;
  • Choi, Young Wook (Drug Delivery Research Lab, College of Pharmacy, Chung-Ang University)
  • 투고 : 2017.11.17
  • 심사 : 2017.11.23
  • 발행 : 2017.12.31

초록

Purpose: Poloxamer 407 (P407) thermo-sensitive hydrogel formulations were developed to enhance the retention time in the urinary bladder after intravesical instillation. Materials and Methods: P407 hydrogels (P407Gels) containing 0.2 w/w% fluorescein isothiocyanate dextran (FD, MW 4 kDa) as a fluorescent probe were prepared by the cold method with different concentrations of the polymer (20, 25, and 30 w/w%). The gel-forming capacities were characterized in terms of gelation temperature (G-Temp), gelation time (G-Time), and gel duration (G-Dur). Homogenous dispersion of the probe throughout the hydrogel was observed by using fluorescence microscopy. The in vitro bladder simulation model was established to evaluate the retention and drug release properties. P407Gels in the solution state were administered to nude mice via urinary instillation, and the in vivo retention behavior of P407Gels was visualized by using an in vivo imaging system (IVIS). Results: P407Gels showed a thermo-reversible phase transition at $4^{\circ}C$ (refrigerated; sol) and $37^{\circ}C$ (body temperature; gel). The G-Temp, G-Time, and G-Dur of FD-free P407Gels were approximately $10^{\circ}C-20^{\circ}C$, 12-30 seconds, and 12-35 hours, respectively, and were not altered by the addition of FD. Fluorescence imaging showed that FD was spread homogenously in the gelled P407 solution. In a bladder simulation model, even after repeated periodic filling-emptying cycles, the hydrogel formulation displayed excellent retention with continuous release of the probe over 8 hours. The FD release from P407Gels and the erosion of the gel, both of which followed zero-order kinetics, had a linear relationship ($r^2=0.988$). IVIS demonstrated that the intravesical retention time of P407Gels was over 4 hours, which was longer than that of the FD solution (<1 hour), even though periodic urination occurred in the mice. Conclusions: FD release from P407Gels was erosion-controlled. P407Gels represent a promising system to enhance intravesical retention with extended drug delivery.

키워드

과제정보

연구 과제 주관 기관 : Korea Health Industry Development Institute (KHIDI)

피인용 문헌

  1. 비이온 양친매성 분자 2-(2-Hexyloxyethoxy)ethanol 수용액의 과잉 부피 vol.37, pp.3, 2020, https://doi.org/10.12925/jkocs.2020.37.3.516
  2. Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer vol.17, pp.11, 2020, https://doi.org/10.1080/17425247.2020.1810016
  3. Poloxamer 407‐based Floating Hydrogels for Intravesical Instillation: Statistical Optimization Using Central Composite Design, Gel Erosion, and Drug Release vol.42, pp.1, 2017, https://doi.org/10.1002/bkcs.12160
  4. Cytotoxic Activity of LLO Y406A Is Targeted to the Plasma Membrane of Cancer Urothelial Cells vol.22, pp.7, 2017, https://doi.org/10.3390/ijms22073305
  5. Optimization of a floating poloxamer 407-based hydrogel using the Box-Behnken design: in vitro characterization and in vivo buoyancy evaluation for intravesical instillation vol.163, pp.None, 2017, https://doi.org/10.1016/j.ejps.2021.105885